Lauren Silvernail
Chief Financial Officer
Finance at University Of Piraeus
Luxembourg
Biography
Silvernail brings to Nicox more than 30 years of experience in leading business growth and financial strategies for life science companies, including nine years at ISTA Pharmaceuticals, a commercial ophthalmic company that was acquired by Bausch + Lomb in 2012. Mrs. Silvernail currently serves as Chief Financial Officer and Chief Business Officer of Revance Therapeutics, Inc. where she led its 2014 initial public offering and has raised more than $450 million in capital since joining that company.
Research Interest
Bipohysics
